Nexvet Biopharma plc·4

Aug 2, 9:34 PM ET

Kilty Cormac G 4

4 · Nexvet Biopharma plc · Filed Aug 2, 2017

Insider Transaction Report

Form 4
Period: 2017-07-31
Transactions
  • Disposition to Issuer

    Ordinary Shares

    2017-07-31$6.72/sh144,364$970,1260 total
  • Disposition to Issuer

    Ordinary Shares

    2017-07-31$6.72/sh10,800$72,5760 total
Footnotes (2)
  • [F1]Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired the Issuer (the "Acquisition")
  • [F2]Shares are held jointly with spouse.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT